WAVE Life Sciences wavelifesciences.com


Public list: BIO 2016 (619) Pharma Startups (4732) Rare Diseases (230)

WAVE Life Sciences is utilizing its synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. Given the versatility of its chemistry platform, WAVE's pipeline is designed to span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.

WAVE Life Sciences is utilizing its synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment ...Show all

Company (IPO / Went public)

Phone: 617-206-4830

Fax:

419 Western Avenue

Brighton, 02135
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
WAVE Life Sciences $186.1M Nov 11, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related WAVE Life Sciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Chiral control Jul 12, 2013 May 29, 2018 Patent
Nucleic acid prodrugs and methods of use thereof Jul 06, 2010 Aug 29, 2017 Patent
Method for the synthesis of phosphorus atom modified nucleic acids May 27, 2016 Jul 04, 2017 Patent
Chiral nucleic acid adjuvant Jul 12, 2013 Apr 11, 2017 Patent
Methods for the synthesis of functionalized nucleic acids Jul 13, 2012 Mar 28, 2017 Patent
See all 16 patents